FDA Awards Clearance for LungVision Navigation System to Revolutionize the Treatment of Lung Lesions

☞ | View the text of this post. Exclusively available to ASQ Members.

Medical device company Body Vision Medical reported on Monday the receipt of clearance from the U.S. Food and Drug Administration (FDA) to market its first LungVision platform to the medical community to revolutionize, diagnose and treat peripheral lung lesions.

LungVision, which is a novel imaging system that enables accurate real-time navigation and lesion localization during bronchoscopic procedures, demonstrated outstanding results through the company’s multicenter clinical trials in the U.S.

Utilizing a sophisticated augmented reality approach, LungVision allows

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *